Max Robotics — Global Service Robot Directory + US Certification

About

Gabriel Farante is a leading figure in the advancement of robotic breast surgery, a field where he has made transformative contributions. His research focuses on refining minimally invasive techniques to improve surgical, oncologic, and quality-of-life outcomes for women with breast cancer or BRCA mutations. Farante’s most impactful work, the 2021 randomized trial comparing robotic mastectomy to open surgery, has garnered 100 citations and is considered a landmark study. It provided critical evidence on the feasibility and benefits of the robotic approach, helping to shift clinical practice. His earlier 2019 review, with 88 citations, systematically charted the field’s progress, establishing a roadmap for future innovation. Through these contributions, Farante has not only advanced surgical precision but also championed patient-centered care, reducing recovery times and improving cosmetic results. His work continues to inspire a new generation of surgeons to embrace technology in the fight against breast cancer.